Clinical Trial Update: Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies [Phase 1]

View source ↗

Summary

A Phase 1b safety study of IMSB301 in Type 1 interferonopathies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Interferonopathies

Drugs mentioned

• IMSB301

Snippet

Sponsor: ImmuneSensor Therapeutics Inc. | Conditions: Type 1 Interferonopathies | Phase 1 | Status: RECRUITING